1. Creating Competitive Advantage for the Swedish Stem Cell Industry ------ The Role of Social Capital and Social Networks Andrew Schenkel & Robin Teigland Stockholm School of Economics June 2007
2.
3.
4.
5. The Stem Cell Network: Industry Level Pharmaceutical/ Biotech/ Marketing Companies STEM CELL FIRMS Financial Actors Academia and Research Actors Government and Regulatory Bodies
6. Stem Cell Network Universities Financial Actors CROs Professional Assocs. KOLs Advisory Boards Pharma Firms Biotech Firms Regulators Government Research Institutes Research Area 3 Research Area 2 Staff & Quality Research Area 1 Stakeholder Relations Finance, Legal, IT STEM CELL FIRM Media Chemical
7. Example of a Firm’s Internal Network with Rich Linkages Note: Nodes represent individuals in departments. Nodes of same color are in same department. Line represents one tie between individuals.
![Today’s Agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)